{"id":"https://openalex.org/W3202089696","doi":"https://doi.org/10.1182/bloodadvances.2021005614","title":"Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia","display_name":"Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia","publication_year":2021,"publication_date":"2021-10-06","ids":{"openalex":"https://openalex.org/W3202089696","doi":"https://doi.org/10.1182/bloodadvances.2021005614","mag":"3202089696","pmid":"https://pubmed.ncbi.nlm.nih.gov/34614509","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9153019"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2021005614","doi":"https://doi.org/10.1182/bloodadvances.2021005614","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005614","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/5/23/5041/1848860/advancesadv2021005614.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/5/23/5041/1848860/advancesadv2021005614.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036117354","display_name":"Megan E. Zavorka Thomas","orcid":"https://orcid.org/0009-0006-4825-8168","observed_orcids":["https://orcid.org/0009-0006-4825-8168"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan E. Zavorka Thomas","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023885813","display_name":"Jae Yoon Jeon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jae Yoon Jeon","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101783607","display_name":"Zahra Talebi","orcid":"https://orcid.org/0000-0001-9166-5160","observed_orcids":["https://orcid.org/0000-0001-9166-5160"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zahra Talebi","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":"https://orcid.org/0000-0001-9166-5160","affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019289825","display_name":"Daelynn R. Buelow","orcid":"https://orcid.org/0000-0002-4413-5711","observed_orcids":["https://orcid.org/0000-0002-4413-5711"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daelynn R. Buelow","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069427165","display_name":"Josie A. Silvaroli","orcid":"https://orcid.org/0000-0002-4505-3670","observed_orcids":["https://orcid.org/0000-0002-4505-3670"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Josie Silvaroli","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":"https://orcid.org/0000-0002-4505-3670","affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060760341","display_name":"Moray J. Campbell","orcid":"https://orcid.org/0000-0002-3355-0928","observed_orcids":["https://orcid.org/0000-0002-3355-0928"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Moray J. Campbell","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065279964","display_name":"Alex Sparreboom","orcid":"https://orcid.org/0000-0003-2660-6644","observed_orcids":["https://orcid.org/0000-0003-2660-6644"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Sparreboom","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063733931","display_name":"Navjotsingh Pabla","orcid":"https://orcid.org/0000-0001-9408-0539","observed_orcids":["https://orcid.org/0000-0001-9408-0539"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Navjot Pabla","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077260725","display_name":"Sharyn D. Baker","orcid":"https://orcid.org/0000-0003-3062-3252","observed_orcids":["https://orcid.org/0000-0003-3062-3252"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sharyn D. Baker","raw_affiliation_strings":["Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5077260725"],"corresponding_institution_ids":["https://openalex.org/I52357470"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":0.9745,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.75291048,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"5","issue":"23","first_page":"5041","last_page":"5046"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12030","display_name":"S100 Proteins and Annexins","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":0.9539999961853027},{"id":"https://openalex.org/keywords/s100a9","display_name":"S100A9","score":0.9470000267028809},{"id":"https://openalex.org/keywords/s100a8-a9","display_name":"S100A8/A9","score":0.9769999980926514},{"id":"https://openalex.org/keywords/bcl6","display_name":"BCL6","score":0.9860000014305115},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.9269999861717224},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitor-resistance","display_name":"tyrosine kinase inhibitor resistance","score":0.9369999766349792},{"id":"https://openalex.org/keywords/calcium-binding-proteins","display_name":"calcium-binding proteins","score":0.9240000247955322},{"id":"https://openalex.org/keywords/free-calcium","display_name":"free calcium","score":0.656000018119812},{"id":"https://openalex.org/keywords/corepressors","display_name":"corepressors","score":0.8299999833106995},{"id":"https://openalex.org/keywords/drug-resistance-mechanisms","display_name":"drug resistance mechanisms","score":0.5690000057220459},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C2776307749","wikidata":"https://www.wikidata.org/wiki/Q18031354","display_name":"S100A9","level":3,"score":0.5787104368209839},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.49218884110450745},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4501492977142334},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4389049708843231},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3983742296695709},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3229420781135559},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3038403391838074},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.06913131475448608}],"mesh":[{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051560","descriptor_name":"Proto-Oncogene Proteins c-bcl-6","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2021005614","doi":"https://doi.org/10.1182/bloodadvances.2021005614","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005614","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/5/23/5041/1848860/advancesadv2021005614.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9153019","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9153019","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:34614509","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34614509","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2021005614","doi":"https://doi.org/10.1182/bloodadvances.2021005614","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005614","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/5/23/5041/1848860/advancesadv2021005614.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2564957956","display_name":"Tyrosine kinase inhibitors for the treatment of childhood AML","funder_award_id":"R01CA138744","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G36614667","display_name":null,"funder_award_id":"CA016058","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000266250","display_name":null,"funder_award_id":"CA016058","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000887552","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016058","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320309374","display_name":"Ohio State University","ror":"https://ror.org/00rs6vg23"},{"id":"https://openalex.org/F4320316230","display_name":"Pelotonia","ror":"https://ror.org/05jcvqz82"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3202089696.pdf","grobid_xml":"https://content.openalex.org/works/W3202089696.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1495575342","https://openalex.org/W1867383795","https://openalex.org/W1978415870","https://openalex.org/W2017656054","https://openalex.org/W2022297793","https://openalex.org/W2023019884","https://openalex.org/W2023505800","https://openalex.org/W2073205505","https://openalex.org/W2112588641","https://openalex.org/W2143835472","https://openalex.org/W2346740876","https://openalex.org/W2517883814","https://openalex.org/W2558945204","https://openalex.org/W2582670998","https://openalex.org/W2615038909","https://openalex.org/W2755848776","https://openalex.org/W2806434239","https://openalex.org/W2885804435","https://openalex.org/W2887344461","https://openalex.org/W2912675416","https://openalex.org/W2949007626","https://openalex.org/W3108510821","https://openalex.org/W3135333594","https://openalex.org/W3200332852"],"related_works":["https://openalex.org/W4284685229","https://openalex.org/W7108469900","https://openalex.org/W3135288982","https://openalex.org/W3214227438","https://openalex.org/W4413923580","https://openalex.org/W4367602775","https://openalex.org/W4317788390","https://openalex.org/W4409151180","https://openalex.org/W4389231637","https://openalex.org/W3088000764"],"abstract_inverted_index":{"Drug":[0],"resistance":[1,44,78,176],"and":[2,51,61,71,94,97,102,131],"relapse":[3],"are":[4],"common":[5],"challenges":[6],"in":[7,13,79,92,95],"acute":[8],"myeloid":[9],"leukemia":[10],"(AML),":[11],"particularly":[12],"an":[14],"aggressive":[15],"subset":[16],"bearing":[17],"internal":[18],"tandem":[19],"duplications":[20],"(ITDs)":[21],"of":[22,37,83,105,128,149,155,167,175,181,194],"the":[23,35,52,67,121,139,152,191],"FLT3":[24,41],"receptor":[25],"(FLT3-ITD+).":[26],"The":[27],"tyrosine":[28],"kinase":[29],"inhibitor":[30],"gilteritinib":[31,46,77,88,134,178],"is":[32,163],"approved":[33],"for":[34],"treatment":[36],"relapse/refractory":[38],"AML":[39,85,158],"with":[40,109],"mutations,":[42],"yet":[43],"to":[45,76,87,112,138,177,189],"remains":[47],"a":[48,115,126,164,182],"clinical":[49],"concern,":[50],"underlying":[53],"mechanisms":[54,174],"remain":[55],"incompletely":[56],"understood.":[57],"Using":[58,114],"transcriptomic":[59],"analyses":[60],"functional":[62,165],"validation":[63],"studies,":[64],"we":[65,119],"identified":[66,120],"calcium-binding":[68],"proteins":[69],"S100A8":[70],"S100A9":[72,106,129,140,144,162],"(S100A8/A9)":[73],"as":[74,125],"contributors":[75],"FLT3-ITD+":[80,84,157],"AML.":[81],"Exposure":[82],"cells":[86],"increased":[89],"S100A8/A9":[90],"expression":[91,130],"vivo":[93],"vitro":[96],"decreased":[98,135],"free":[99],"calcium":[100],"levels,":[101],"genetic":[103],"manipulation":[104],"was":[107],"associated":[108],"altered":[110],"sensitivity":[111],"gilteritinib.":[113,195],"transcription":[116],"factor":[117],"screen,":[118],"transcriptional":[122],"corepressor":[123],"BCL6,":[124],"regulator":[127],"found":[132],"that":[133,161,184],"BCL6":[136,150],"binding":[137],"promoter,":[141],"thereby":[142],"increasing":[143],"expression.":[145],"Furthermore,":[146],"pharmacological":[147],"inhibition":[148],"accelerated":[151],"growth":[153],"rate":[154],"gilteritinib-resistant":[156],"cells,":[159],"suggesting":[160],"target":[166,183],"BCL6.":[168],"These":[169],"findings":[170],"shed":[171],"light":[172],"on":[173],"through":[179],"regulation":[180],"can":[185],"be":[186],"therapeutically":[187],"exploited":[188],"enhance":[190],"antileukemic":[192],"effects":[193]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2021-10-11T00:00:00"}